drugset / Trial / NCT00728689

Phase I Trial of an Investigational Small Pox Medication

NCT00728689

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study was to evaluate the pharmacokinetic parameters and safety of a single dose of ST-246 400mg Form I versus ST-246 400mg Form V capsules in fed normal healthy volunteers.

Timeline

Start
2008-08
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tecovirimat Small molecule 400 mg Oral